Related Experiment Video

Updated: Aug 8, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Use of an indirect effect model to describe the LDL cholesterol-lowering effect by statins in hypercholesterolaemic

Demiana William Faltaos1, Saïk Urien, Valérie Carreau

  • 1Pharmacology Department, Pitié-Salpêtrière University Hospital, Assistance-Publique Hôpitaux de Paris, Paris 6 University, Paris, France. demiana.william@psl.ap-hop-paris.fr

Fundamental & Clinical Pharmacology
|May 5, 2006
PubMed

Insights

This study developed a pharmacokinetic/pharmacodynamic (PK/PD) model to understand how statins like atorvastatin, fluvastatin, and simvastatin lower low-density lipoprotein (LDL) cholesterol. The model accurately predicted the LDL-lowering effects of these common hypercholesterolemia treatments.

Area of Science:

  • Pharmacology
  • Pharmacokinetics and Pharmacodynamics
  • Cardiovascular Medicine

Background:

  • Statins are primary agents for hypercholesterolemia treatment, effectively reducing low-density lipoprotein (LDL) cholesterol.
  • Effective LDL reduction is crucial, especially for patients with multiple risk factors or coronary heart disease.

Purpose of the Study:

  • To develop a pharmacokinetic/pharmacodynamic (PK/PD) model describing the LDL-lowering process in hypercholesterolemia patients treated with atorvastatin, fluvastatin, or simvastatin.
  • To estimate key pharmacodynamic parameters for these statins.

Main Methods:

  • Retrospective analysis of 100 hypercholesterolemia patients (57 atorvastatin, 26 fluvastatin, 17 simvastatin).
  • Utilized an indirect-response model with precursor and response compartments to analyze 309 LDL levels using NONMEM V.
  • Fixed absorption rate and elimination half-lives due to lack of pharmacokinetic data.

Main Results:

  • Estimated LDL input rate (K(in)) at 0.14 g/L/day, inhibition fraction (INH) at 0.21, and D50 values for atorvastatin, simvastatin, and fluvastatin.
  • Identified no significant effect of demographic or clinical factors (gender, weight, age, diet, organ function) on pharmacodynamic parameters.
  • The developed PK/PD model accurately estimated pharmacodynamic parameters and predicted the time course of LDL reduction.

Conclusions:

  • The developed PK/PD model provides an accurate description of the LDL-lowering effects of atorvastatin, fluvastatin, and simvastatin.
  • The model successfully predicts the time course of LDL reduction, aiding in the management of hypercholesterolemia.
  • Pharmacodynamic parameters were robustly estimated, independent of common patient characteristics.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model01:29

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
Pharmacodynamic Models: Logarithmic Concentration–Effect Model01:15

Pharmacodynamic Models: Logarithmic Concentration–Effect Model

The log-linear model is a pharmacological framework used to describe the relationship between drug concentration and its effect. This model is particularly relevant when the observed effects range between 20% and 80% of the drug’s maximum effect (Emax), where a near-linear relationship is observed between the log of drug concentration and the measured effect. However, the log-linear model does not predict the maximum possible effect (Emax) or the effect at zero drug concentration, limiting its...
Pharmacodynamic Models: Linear Concentration–Effect Model01:15

Pharmacodynamic Models: Linear Concentration–Effect Model

The linear concentration–effect model, underpinned by the principle that pharmacological effect (E) is directly proportional to plasma drug concentration (C), emerges as a pivotal simplification of the Emax model for conditions where C is significantly less than EC50. This model portrays a linear trajectory of the concentration–effect relationship when drug levels are markedly below the EC50 threshold.Despite its inherent assumption of continuous effect augmentation with increasing drug...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...